SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Robert G. Hanah who wrote (921)11/20/1998 12:34:00 AM
From: dwight martin  Read Replies (1) | Respond to of 1972
 
If the target is $100 why is it a buy only up to $17?



To: Robert G. Hanah who wrote (921)11/20/1998 12:53:00 PM
From: Kushi Kullar  Respond to of 1972
 
It is probably a Michael Murphy recommendation. So
FWIW.....



To: Robert G. Hanah who wrote (921)11/25/1998 8:51:00 AM
From: Henry Niman  Respond to of 1972
 
Yesterday, BancBoston Robertson Stephens (BBRS) held a conference call on the Health Sciences Conference which begins on Monday in NY. They mentioned several companies, including VICL. Details linked to the Biotech Boom table at biocognizance.com or webf2179.ntx.net



To: Robert G. Hanah who wrote (921)11/29/1998 4:14:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 1972
 
Tomorrow the BankBoston Robertson Stephens Health Care Conference in
NY begins. A list of presenting companies is linked to the Biotech Boom table at biocognizance.com or webf2179.ntx.net


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News